Global Hemoperfusion Cartridge Market Growth 2023-2029

Global Hemoperfusion Cartridge Market Growth 2023-2029

The hemoperfusion device (that is, the disposable hemoperfusion device) is an essential key medical device for hemoperfusion.

During hemoperfusion (HP), blood circulates through an extracorporeal circuit equipped with a charcoal or resin cartridge onto which the poison can be adsorbed.

LPI (LP Information)' newest research report, the “Hemoperfusion Cartridge Industry Forecast” looks at past sales and reviews total world Hemoperfusion Cartridge sales in 2022, providing a comprehensive analysis by region and market sector of projected Hemoperfusion Cartridge sales for 2023 through 2029. With Hemoperfusion Cartridge sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hemoperfusion Cartridge industry.

This Insight Report provides a comprehensive analysis of the global Hemoperfusion Cartridge landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hemoperfusion Cartridge portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Hemoperfusion Cartridge market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hemoperfusion Cartridge and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hemoperfusion Cartridge.

The global Hemoperfusion Cartridge market size is projected to grow from US$ 714.5 million in 2022 to US$ 2199.8 million in 2029; it is expected to grow at a CAGR of 2199.8 from 2023 to 2029.

The global top five hemoperfusion cartridge manufacturers include Baxter International, Baihe Medical, Asahi Kasei Corporation, Toray Medical, and Jafron Biomedical, which together account for more than 90% of the market share. The largest manufacturer is Baxter International, with a market share of more than 50%. The Asia-Pacific region is the global most important consumer market for hemoperfusion cartridge, with a market share of more than 75%. In terms of type, resin adsorption has a market share of over 85%. In the field of application, the market share of hospitals has reached more than 80%.

This report presents a comprehensive overview, market shares, and growth opportunities of Hemoperfusion Cartridge market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Activated Carbon Adsorption
Resin Adsorption

Segmentation by application
Hospital
Clinic
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Baxter International
Asahi Kasei Corporation
Toray Medical
Jafron Biomedical
Kaneka Medix Corporation
CytoSorbents
Baihe Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Hemoperfusion Cartridge market?

What factors are driving Hemoperfusion Cartridge market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Hemoperfusion Cartridge market opportunities vary by end market size?

How does Hemoperfusion Cartridge break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.